Cargando…
Development of Follicle-Stimulating Hormone Receptor Binding Probes to Image Ovarian Xenografts
The Follicle-Stimulating Hormone Receptor (FSHR) is used as an imaging biomarker for the detection of ovarian cancer (OC). FSHR is highly expressed on ovarian tumors and involved with cancer development and metastatic signaling pathways. A decapeptide specific to the FSHR extracellular domain is syn...
Autores principales: | Lee, Chung-Wein, Guo, Lili, Matei, Daniela, Stantz, Keith |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4712933/ https://www.ncbi.nlm.nih.gov/pubmed/26779384 http://dx.doi.org/10.4172/2155-952X.1000198 |
Ejemplares similares
-
Profile of follicle-stimulating hormone and polymorphism of follicle-stimulating hormone receptor in Madrasin cattle with ovarian hypofunction
por: Utomo, Budi, et al.
Publicado: (2020) -
Development of a mathematical model to estimate intra-tumor oxygen concentrations through multi-parametric imaging
por: Lee, Chung-Wein, et al.
Publicado: (2016) -
Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome
por: Schniewind, Hanna A., et al.
Publicado: (2021) -
OR24-04 Ovarian Follicle Survival Is Determined by Follicle-Stimulating Hormone Receptor (FSHR) and Estrogen Receptor (GPER) Heteromers
por: Casarini, Livio, et al.
Publicado: (2020) -
Membrane Estrogen Receptor (GPER) and Follicle-Stimulating Hormone Receptor (FSHR) Heteromeric Complexes Promote Human Ovarian Follicle Survival
por: Casarini, Livio, et al.
Publicado: (2020)